Meta, IBD Stock Of The Day, In A Buy Zone Even As Mag 7 Stocks Stall
S&P 500 giant Meta Platforms is Friday's IBD Stock Of The Day, as the Facebook-parent declined slightly during market trade but is in a buy zone from an official entry amid Meta's nearly 60% rally this year. The Facebook and Instagram parent company at the end of July cleared Q2 estimates with a 73% increase in earnings on 22% revenue growth. Shares of Meta have galloped 18% higher since that earnings report as the company has pivoted from the metaverse to focus on its artificial intelligence ambitions.